BALDI, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 2.506
AS - Asia 1.236
EU - Europa 773
SA - Sud America 165
AF - Africa 25
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.713
Nazione #
US - Stati Uniti d'America 2.462
SG - Singapore 503
CN - Cina 392
IT - Italia 219
BR - Brasile 139
HK - Hong Kong 134
DE - Germania 113
GB - Regno Unito 102
UA - Ucraina 102
TR - Turchia 68
FI - Finlandia 62
VN - Vietnam 56
SE - Svezia 37
RU - Federazione Russa 32
CA - Canada 22
BE - Belgio 18
ID - Indonesia 18
MX - Messico 18
NL - Olanda 18
PL - Polonia 16
ZA - Sudafrica 16
FR - Francia 15
IN - India 15
JP - Giappone 15
AR - Argentina 10
AT - Austria 9
CZ - Repubblica Ceca 9
IQ - Iraq 9
ES - Italia 6
IR - Iran 6
AU - Australia 5
PK - Pakistan 5
BD - Bangladesh 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
EG - Egitto 3
HN - Honduras 3
LT - Lituania 3
UZ - Uzbekistan 3
AO - Angola 2
EC - Ecuador 2
HU - Ungheria 2
KR - Corea 2
LV - Lettonia 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
HR - Croazia 1
IE - Irlanda 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
Totale 4.713
Città #
Ashburn 306
Singapore 296
Woodbridge 236
Fairfield 182
Chandler 161
Beijing 148
Hong Kong 134
Houston 132
Santa Clara 132
Ann Arbor 131
Jacksonville 110
Ferrara 80
Dallas 76
Wilmington 58
Cambridge 57
Seattle 57
Los Angeles 56
New York 49
Milan 43
Nanjing 41
Izmir 40
Princeton 32
Munich 31
Shanghai 30
Boardman 29
Dearborn 29
Addison 21
Ho Chi Minh City 20
Brussels 18
Helsinki 17
Turku 17
Buffalo 16
Denver 16
Jakarta 16
London 16
Warsaw 16
San Diego 15
Tokyo 15
Nanchang 14
São Paulo 14
Brooklyn 13
The Dalles 13
Bremen 12
Hanoi 12
Shenyang 12
Chennai 11
Bologna 10
Chicago 10
Mexico City 10
Phoenix 10
Hefei 9
Jiaxing 9
Tianjin 9
Changsha 8
Frankfurt am Main 8
Norwalk 8
Orem 8
Atlanta 7
Brno 7
Jinan 7
Rome 7
Stockholm 7
Toronto 7
Vienna 7
Auburn Hills 6
Falkenstein 6
Hebei 6
Johannesburg 6
Poplar 6
San Francisco 6
Amsterdam 5
Des Moines 5
Guangzhou 5
Montreal 5
Ningbo 5
Redwood City 5
Rio de Janeiro 5
San Mateo 5
Turin 5
Washington 5
Baghdad 4
Brasília 4
Cape Town 4
Columbus 4
Lima 4
Moscow 4
Nuremberg 4
Porto Alegre 4
Querétaro 4
Ankara 3
Augusta 3
Biên Hòa 3
Boston 3
Charlotte 3
Cleveland 3
Dong Ket 3
Hangzhou 3
Hải Dương 3
Indiana 3
Kunming 3
Totale 3.283
Nome #
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 213
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 193
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 185
Epidemiological health and social study on multiple sclerosis in the Ferrara province 182
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 177
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 175
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 162
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 160
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 160
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 155
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 153
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 148
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 148
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 143
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 143
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 134
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 130
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 123
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients 122
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 120
Smaller optic nerve diameters and reduced flow velocity of ophthalmic artery suggest a history of optic neuritides: Transorbital Ultrasonography and Doppler Ultrasound in multiple sclerosis 119
Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study 117
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study 114
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 108
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 108
null 104
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 104
The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis 103
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 98
null 90
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 89
MMP-9 isoforms in serum of Multiple Sclerosis patients 88
Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS 70
null 66
null 66
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 62
Soluble HLA-G molecules are preponderantly released as HLA-G5 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. 49
null 45
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 44
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 6
Sex-specific optic nerve changes in multiple sclerosis and transorbital sonography. The PROMISING study 2
Totale 4.778
Categoria #
all - tutte 22.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 33 8 31 14 41 47 23
2021/2022290 8 36 23 5 15 11 14 14 13 25 24 102
2022/2023381 34 44 9 58 56 41 27 37 33 5 22 15
2023/2024312 23 15 9 4 37 50 19 34 17 18 22 64
2024/2025865 24 29 70 49 103 87 28 39 132 78 138 88
2025/20261.358 278 72 214 332 408 54 0 0 0 0 0 0
Totale 4.778